{"url":"https://lda.senate.gov/api/v1/filings/47553295-eaf6-46ed-b294-68539bce3e68/","filing_uuid":"47553295-eaf6-46ed-b294-68539bce3e68","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2017,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/47553295-eaf6-46ed-b294-68539bce3e68/print/","filing_document_content_type":"text/html","income":"11250.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"James W. Rock","dt_posted":"2017-04-17T09:27:26.073000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"517 C Street, NE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":33545,"url":"https://lda.senate.gov/api/v1/registrants/33545/","house_registrant_id":30422,"name":"ROCK & ASSOCIATES","description":"Government relations consultant.","address_1":"517 C Street, NE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAMES W. ROCK","contact_telephone":"+1 703-627-8226","dt_updated":"2025-02-03T11:57:31.624210-05:00"},"client":{"id":141935,"url":"https://lda.senate.gov/api/v1/clients/141935/","client_id":90,"name":"DIAMONDBACK DRUGS","general_description":"Independently owned retail pharmacy.","client_government_entity":false,"client_self_select":false,"state":"AZ","state_display":"Arizona","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-04-16"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Legislation pertaining to pharmacy compounding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":22837,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"W","last_name":"ROCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Appropriations for FDA for FY2017 and FY2018","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":22837,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"W","last_name":"ROCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Legislation pertaining to pharmacy compounding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":22837,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"W","last_name":"ROCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Controlled substance issues pertaining to pharmacy compounding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":22837,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"W","last_name":"ROCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}